United Therapeutics

TYVASO

Manufacturer:

United Therapeutics

Tyvaso HCPCS:

J7686

HCPCS Code Descriptor:

Treprostinil, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, 1.74 mg

Category:

J Code

Tyvaso NDCs:

66302-0206-03, 66302-0206-04, 66302-0206-02, 66302-0206-01

Primary Type:

Cardiology

Generic/Specialty Status:

Single-Source

Package Type:

Not Found

Route of Administration:

Inhalation

Tyvaso CPT Codes:

Potential CPT administration codes for Tyvaso can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Tyvaso:

TYVASO is a Cardiology drug manufactured by United Therapeutics and administered via the Inhalation route of administration. The J Code: J7686 is aligned to the drug TYVASO.

ACCESS PRICING AND MORE BY REGISTERING

J7686 Added Date:

January 1, 2011

J7686 Effective Date:

January 1, 2011

J7686 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Tyvaso billing and coding information.
Tyvaso patient assistance information can be found through Archways Patient Support at the URL: https://www.unither.com/patients.html
TYVASO prescribing information can be found at the link below:
Information regarding TYVASO’s side effects can be found at MedlinePlus